Rubius Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Rubius Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2022.
  • Rubius Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2022 was -255 %, a 214% decline year-over-year.
  • Rubius Therapeutics, Inc. annual Return On Equity for 2022 was -255 %, a 214% decline from 2021.
  • Rubius Therapeutics, Inc. annual Return On Equity for 2021 was -81.2 %, a 8.58% increase from 2020.
  • Rubius Therapeutics, Inc. annual Return On Equity for 2020 was -88.8 %, a 76.2% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -255 -174 -214% Jan 1, 2022 Dec 31, 2022
2021 -81.2 +7.62 +8.58% Jan 1, 2021 Dec 31, 2021
2020 -88.8 -38.4 -76.2% Jan 1, 2020 Dec 31, 2020
2019 -50.4 +2.22 +4.22% Jan 1, 2019 Dec 31, 2019
2018 -52.6 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.